Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 8Phase EARLY_PHASE1 6Phase 4 4Phase 1/2 3Phase 1 3Phase 3 1Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 972INDUSTRY 343NIH 42NETWORK 40OTHER_GOV 35FED 8UNKNOWN 6INDIV 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × INDIV × Interventional × Clear all
NCT06836973 2025-03-25

Blinatumomab for Treatment of Refractory Myasthenia Gravis

Da, Yuwei, M.D.

Phase 2/3 Not yet recruiting
2 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡